Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -1.3x - -1.4x | -1.3x |
| Selected Fwd P/E Multiple | -2.5x - -2.7x | -2.6x |
| Fair Value | ₩2,277 - ₩2,517 | ₩2,397 |
| Upside | -19.8% - -11.4% | -15.6% |
| Benchmarks | - | Full Ticker |
| INSAN Inc. | - | KOSDAQ:A277410 |
| Genic Co., Ltd. | - | KOSDAQ:A123330 |
| Outin Futures Co., Ltd | - | KOSDAQ:A227610 |
| Icure Pharmaceutical Incorporation | - | KOSDAQ:A175250 |
| Cosmecca Korea Co., Ltd. | - | KOSDAQ:A241710 |
| Medience Co., Ltd. | - | KOSDAQ:A014100 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| A277410 | A123330 | A227610 | A175250 | A241710 | A014100 | |||
| KOSDAQ:A277410 | KOSDAQ:A123330 | KOSDAQ:A227610 | KOSDAQ:A175250 | KOSDAQ:A241710 | KOSDAQ:A014100 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | -22.3% | NM- | NM- | NM- | 54.5% | NM- | ||
| 3Y CAGR | -48.0% | NM- | NM- | NM- | 68.8% | NM- | ||
| Latest Twelve Months | -82.1% | 271.5% | -2640.1% | 103.3% | 91.8% | -297.2% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 12.6% | -12.0% | -28.8% | -41.7% | 4.1% | 0.9% | ||
| Prior Fiscal Year | 13.3% | -15.7% | -0.8% | -55.3% | 4.7% | 10.6% | ||
| Latest Fiscal Year | 2.7% | 15.2% | -19.5% | 1.5% | 8.2% | -28.1% | ||
| Latest Twelve Months | 2.7% | 15.2% | -19.5% | 1.5% | 8.2% | -28.1% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 22.2x | 23.8x | -27.7x | -8.3x | 8.2x | -1.6x | ||
| Price / LTM Sales | 1.4x | 3.6x | 0.9x | 0.8x | 0.9x | 0.7x | ||
| LTM P/E Ratio | 52.6x | 23.5x | -4.8x | 54.1x | 11.5x | -2.3x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -4.8x | 23.5x | 54.1x | |||||
| Historical LTM P/E Ratio | -3.1x | 4.3x | 55.6x | |||||
| Selected P/E Multiple | -1.3x | -1.3x | -1.4x | |||||
| (x) LTM Net Income | (13,786) | (13,786) | (13,786) | |||||
| (=) Equity Value | 17,340 | 18,252 | 19,165 | |||||
| (/) Shares Outstanding | 11.3 | 11.3 | 11.3 | |||||
| Implied Value Range | 1,534.38 | 1,615.14 | 1,695.90 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 1,534.38 | 1,615.14 | 1,695.90 | 2,840.00 | ||||
| Upside / (Downside) | -46.0% | -43.1% | -40.3% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A277410 | A123330 | A227610 | A175250 | A241710 | A014100 | |
| Value of Common Equity | 46,664 | 177,620 | 37,398 | 56,802 | 492,882 | 32,094 | |
| (/) Shares Outstanding | 37.7 | 7.8 | 35.4 | 37.4 | 10.7 | 11.3 | |
| Implied Stock Price | 1,238.00 | 22,700.00 | 1,055.00 | 1,520.00 | 46,150.00 | 2,840.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,238.00 | 22,700.00 | 1,055.00 | 1,520.00 | 46,150.00 | 2,840.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |